| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
a Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan;
b Kirin Brewery Co., Ltd., Takasaki, Japan;
c Department of Surgery, Showa University School of Medicine, Tokyo, Japan
Key Words. Thrombopoietin • c-mpl • Hepatoblastoma • Thrombocytosis
Dr. Takafumi Matsumura, Department of Pediatrics, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyoku, Kyoto 602-8566, Japan.
Marked thrombocytosis (over 50 x 104/µl) is frequently seen in patients with hepatoblastoma. Thrombopoietin (TPO), c-mpl ligand, has recently been purified as the major physiological regulator of the thrombopoiesis and is mainly produced in the liver. Since it is possible that TPO participates in thrombocytosis and the tumor growth of this particular hepatic tumor, serum TPO levels in addition to interleukin 1ß (IL-1ß) and IL-6 levels were assessed in seven untreated patients by using a sandwich enzyme-linked immunosorbent assay. High serum TPO levels were observed in all of the examined patients. The level ranged from 3.15 to 11.02 (mean ± standard deviation; 6.08 ± 1.25) fmol/ml. IL-6 levels were also somewhat higher than normal. Platelet counts, however, appeared to correlate more with serum TPO levels (p = 0.1) than with IL-1ß (p = 0.5) and IL-6 (p = 0.2) levels. Furthermore, using the reverse transcriptase polymerase chain reaction method, the expression of c-mpl mRNA was found in five of eight hepatoblastoma tissues as well as TPO mRNA in all eight tissues. These observations suggest that thrombocytosis in hepatoblastoma patients results from the production of cytokine members, including TPO, within tumor tissues. Additionally, it is possible that TPO might act as a type of autocrine and/or paracrine system for cellular growth in this tumor.
This article has been cited by other articles:
|
|
 |
|
  J. B. Litten and G. E. Tomlinson Liver Tumors in Children Oncologist, July 1, 2008; 13(7): 812 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Romanelli, I. Petrai, G. Robino, E. Efsen, E. Novo, A. Bonacchi, G. Pagliai, A. Grossi, M. Parola, N. Navari, et al. Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells Am J Physiol Gastrointest Liver Physiol, January 1, 2006; 290(1): G120 - G128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Herzog, R. J. Andrassy, and F. Eftekhari Childhood Cancers: Hepatoblastoma Oncologist, December 1, 2000; 5(6): 445 - 453. [Abstract] [Full Text]
|
|
|
|
 |
|
 S.-S. Luo, K. Ogata, N. Yokose, T. Kato, and K. Dan Effect of Thrombopoietin on Proliferation of Blasts from Patients with Myelodysplastic Syndromes Stem Cells, March 1, 2000; 18(2): 112 - 119. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
